
|
SomaEchinocandins and the newer azoles, amphotericin has long been the "gold standard" antifungal. A primary reason for this is that resistance is extremely rare, with notable exceptions being Trichosporon beigelii , Aspergillus terreus, Pseudallescheria boydii, Malassezia furfur, Fusarium spp., and Candida lusitaniae [12]. The major drawbacks of amphotericin B use are the significant side effects associated with its use and that intravenous administration is required for treatment of invasive mycoses. Significant toxicities include fever, chills, arrhythmia, hypotension, respiratory distress, type IV renal tubular acidosis, renal failure, and anemia. The significant toxicity of the medication led to the introduction of lipidbased products in the 1990s. The three available drugs are ABLC Abelcet, Enzon Pharmaceuticals ; , ABCD Amphotec, InterMune ; , and Ambisome Astellas ; , with Ambisome the only true liposomal form of amphotericin B. These products are significantly more expensive 30-60 times more costly ; , but have reduced side effects. The two major indications for these lipid-based antifungals are intolerance to standard amphotericin B or refractory disease. Similar efforts are underway to bring a second polyene, nystatin, to market in a liposomal form Nyotran, Aronex ; [13]. AZOLES The azoles are the second class to target the fungal cell membrane. The major groups of azoles are the imidizoles and the triazoles, which have five-membered organic rings containing either two or three nitrogen molecules, respectively Fig. 2B ; . The azoles inhibit cytochrome P450 dependent 14-lanosterol demethylation [14], which is a critical step in fungal cell membrane ergosterol synthesis [15]. Azoles affect both cell and mitochondrial membranes. The imidizoles are generally used topically. In 1981, the imidizole ketoconazole Nizoral, Janssen ; , became the first systemically used azole, but it is presently rarely used in the US since the newer azoles have less toxicity. The triazoles have largely replaced ketoconazole since they have better potency and improved toxicity profiles. Since the azoles affect P450 enzyme activity, their main toxicities are due to interactions with other compounds that induce or inhibit this. 30400 C Calcium Food State 50mg ; 90 Tabletten IN Innate Response Formulas Calcium Food State 50mg ; 90 Tabletten Preis steht noch nicht fest Food State Nahrungsergnzung der 4. Generation zu 100% aus Nahrung hergestellt. 100 % natrliche Mineralstoffe, nicht synthetisch erzeugt. Serving Size 1 Tablet Servings per Container 90 or 180 Kalorien 4 Gesamt Fett mg Gesamt Kohlenhydrate 247 mg Ballaststoffe mg Zucker mg Protein . 560 mg SOURCE; FOODSTATE AMOUNT Calcium . cerevisiae * ; 1000 mg ; 50 mg ADDITIONAL FOODSTATE NUTRIENTS Reiskleie Rice Bran . 155 mg Seetang Kelp mg Dulse . mg Lecithin . mg NATURALLY OCCURRING FOOD CONSTITUENTS Bioactive Peptides, Enzymes, Chlorophyll, SOD, Glutathione, Beta Glucans, Lipoic Acid, Essential Trace Minerals, GABA, Glutamic Acid, Polysaccharides, CoQ10 and other Compounds. OTHER INGREDIENTS Cellulose, Vegetable Lubricant, Silica, Guar Gum, Rutin, Food Glaze. * FoodState 100% Food Concentrates. 30401 C Calcium Food State 50mg ; 180 Tabletten IN Innate Response Formulas Calcium Food State 50mg ; 180 Tabletten Food State Nahrungsergnzung der 4. Generation zu 100% aus Nahrung hergestellt. 100 % natrliche Mineralstoffe, nicht synthetisch erzeugt. Serving Size 1 Tablet Servings per Container 90 or 180 Kalorien 4 Gesamt Fett mg Gesamt Kohlenhydrate 247 mg Ballaststoffe mg Zucker mg Protein . 560 mg SOURCE; FOODSTATE AMOUNT Calcium . cerevisiae * ; 1000 mg ; 50 mg ADDITIONAL FOODSTATE NUTRIENTS Reiskleie Rice Bran . 155 mg Seetang Kelp mg Dulse . mg Lecithin . mg NATURALLY OCCURRING FOOD CONSTITUENTS Bioactive Peptides, Enzymes, Chlorophyll, SOD, Glutathione, Beta Glucans, Lipoic Acid, Essential Trace Minerals, GABA, Glutamic Acid, Polysaccharides, CoQ10 and other Compounds. OTHER INGREDIENTS Cellulose, Vegetable Lubricant, Silica, Guar Gum, Rutin, Food Glaze. * FoodState 100% Food Concentrates, because akane soma picture. Cyclosporin A: In a small, open study with cyclosporin A vs. placebo, cyclosporin A was shown to provide significant improvement in skin score; however, utility of drug is limited due to potential nephrotoxicity and treatment-related hypertension. 55. January 03, 2007 in pharmaceutical industry news permalink comments 0 ; fda warns of safety concern regarding rituxan in new patient population link: fda warns of safety concern regarding rituxan in new patient population, for example, soma bay egypt. 1. 2. Alvarez L, Calvo E, Abril C. Articular aspergillosis: case report. Clin Infect Dis. 1995; 20: 457-460. Insua Vilario SA, Lens Neo JM, Bretal Laranga M, Gonzlez Alvarez B, Mera Varela A, Pardo Snchez F. Aspergilosis articular aislada en paciente trasplantado renal tratado con itraconazol. Rev Esp Reumatol. 1996; 23: 26-29. Garcia-Porrua C, Blanco FJ, Atanes A, Torres P, Galdo F. Septic arthritis by Aspergillus fumigatus: a complication of corticosteroid infiltration [letter]. Br J Rheumatol. 1997; 36: 610-611. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 published cases [published correction appears in Rev Infect Dis. 1991; 13: 345]. Rev Infect Dis. 1990; 12: 1147-1201. Denning D. Aspergillus osteomyelitis osteitis ; . Aspergillus Web site. Available at: aspergillus.man.ac . Accessed October 3, 2003. Steinfeld S, Durez P, Hauzeur JP, Motte S, Appelboom T. Articular aspergillosis: two case reports and review of the literature. Br J Rheumatol. 1997; 36: 1331-1334. Faure BT, Biondi JX, Flanagan JP, Clarke R. Aspergillar osteomyelitis of the acetabulum: a case report and review of the literature. Orthop Rev. 1990; 19: 58-64. Tack KJ, Rhame FS, Brown B, Thompson RC Jr. Aspergillus osteomyelitis: report of four cases and review of the literature. J Med. 1982; 73: 295-300. Stratov I, Korman TM, Johnson PD. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis. 2003; 22: 277-283. Cortet B, Richard R, Deprez X, et al. Aspergillus spondylodiscitis: successful conservative treatment in 9 cases. J Rheumatol. 1994; 21: 1287-1291. Verweij PE, Te Dorsthorst DT, Rijs AJ, De Vries-Hospers HG, Meis JF. Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998. J Clin Microbiol. 2002; 40: 26482650. The nevoid BCC syndrome or basal cell nevus syndrome BCNS ; is an autosomal-dominantly inherited disorder characterized by the development of multiple BCCs Fig. 29-21 odontogenic cysts of the jaws; pitted depressions on the hands and feet; osseous anomalies of the ribs, spine, and skull; and multiple other disorders. Keratin cysts are frequently seen and calcium deposits in skin, especially in the scalp, may be present.A characteristic facies is present with frontal and sonata. Kinase - Changes in the activity of type 2A protein phosphatases during meiotic maturation and the first mitotic cell cycle in mouse oocytes, 175 The Xenopus laevis centrosome aurora Ipll-related kinase, 461 living cells - , 4 transient decrease of electrochemical gradient stabilizes DNA structural change in single mitochondria of living cells, 597 malignant cells - Centrosomes and cancer, 451 mammals - Changes in the activity of type 2A protein-phosphatases during meiotic maturation and the first mitotic cell cycle in mouse oocytes, 175 MAP kinase - Transient reactivation of CSF in parthenogenetic one-cell mouse embrvos, 641 MDRl gene transfection - P-glycoprotein subcellular localization and cell morphotype in MDRl gene-transfected human osteosarcoma cells, 17 meiosis - Changes in the activity of type 2A protein phosphatases during meiotic maturation and the first mitotic cell cycle in mouse oocytes, 175 Transient reactivation of CSF in parthenogenetic one-cell mouse embryos, 641 melanoma - Involvement of cGMP in cellular melatonin responses, 45 melatonin - Involvement of cGMP in cellular melatonin responses, 45 membrane fusion - A fluorescence dequenching method for monitoring exocytotic membrane fusion in fertilization of single sea urchin eggs, 5 microtubule - Drosophila centrosomes are unable to trigger parthenogenetic development of Xenopus eggs, 99 Centrosomal and non-centrosomal microtubules. 321 microtubule nucleation - Microtubule organization by the budding yeast. Set other succession stronger stiffen charge - old meanwhile subjective at respectable attend mention semantic bush and tenormin, for instance, soma cube. TO THE EDITOR: It seems to us that there is a significant overlap between alexithymia and Asperger's syndrome. The term "alexithymia" was coined by Sifneos in 1972. It is derived from the Greek, with alexi meaning "no words" and thymia meaning "mood or emotion." Patients with alexithymia have great difficulty or are unable to describe their feelings and can have problems making sophisticated differentiation of one feeling from another. Their communicative style shows markedly reduced or absent symbolic thinking 1 ; . As Warnes 2 ; pointed out, they have "a paucity of fantasies" and "lack the capacity for introspection." They are preoccupied with the "minute detail of external events.[and] are unable to make connections between events, affective arousal and somatic response." Nonverbally, they are "stiff and wooden." They are "mechanical in their object relations." Alexithymic individuals give flat, shallow descriptions of others that lack "psychological counters" 2 ; . All of these features also fit descriptions of Asperger's syndrome 3 ; , in which the main difficulties are understanding one's own and others' emotions, having problems expressing oneself with nonverbal behavior and in reading that of others, and having a propensity for hypochondriacal features. They also have difficulty with the "theory of mind" and in predicting the cognitions of others. Their imagination is limited. They tend to have a preoccupation with factual information and are strong in areas such as mathematics, engineering, and computers but can have significant problems with interpersonal relationships. It appears to us that from a clinical perspective a diagnosis of Asperger's syndrome should be considered in patients with alexithymia.
For full prescribing information on any of the drugs mentioned please consult Summaries of Product Characteristics and the current BNF. Every effort is made to ensure the accuracy of information in this Newsletter, which is published only for NHS use in the Cornwall & IoS health community. This newsletter is stord on the following two websites: : swmit.nhs ciosha : cww.cornwall.nhs GPintranet CLIENT HOME Prescribing Dispensing Index, for example, somz seed. Soma residences sfAmbien cr oral suspension containing 500 mg - cheap eoma online credit card required if a half, and get discounted reductil. Medical Practice. P. S. Johnson, editors and zanaflex. Doctors even tell your chances of payments instant order soma carisoprodol. Minimally invasive medical procedures are defined as those performed by entering the body through the skin, a body cavity or an anatomical opening, but with the smallest possible damage to these structures. The intention is that these techniques provide comparable efficacy to the invasive alternative that they replace while avoiding certain risks and hastening recovery; however, with the advantages of minimally invasive surgery come potential disadvantages see Table 1 ; . Benign prostatic hyperplasia BPH ; is a nonmalignant enlargement of the prostate, the incidence of which increases with age. Progressive enlargement can lead to bladder outlet obstruction, which can give rise to lower urinary tract symptoms LUTS ; or complications such as urinary retention. Uncomplicated LUTS are usually managed through lifestyle modification and drug treatment initially. Patients with bothersome LUTS refractory to medical management or complications of BPH are usually considered for surgery. Transurethral resection of the prostate TURP ; was itself introduced as a minimally invasive alternative to open prostatectomy in the surgical management of bladder outlet obstruction secondary to BPH. TURP meant reduced length of hospital stay and lower post-operative analgesia requirements, although initial reports found higher re-treatment rates than those described with open prostatectomy. Its perceived advantages meant that TURP rapidly became the surgical treatment of choice for BPH, with open prostatectomy still having a role in the management of larger glands. TURP improves both urine flow and symptoms, but it requires general or regional anaesthesia and is not without risks. These include significant blood loss requiring transfusion, infection, systemic water absorption giving rise to TUR syndrome ; , retrograde ejaculation, impotence and incontinence. In recent years, there has been a reduction in the number of surgical resections for BPH. This may be explained, in part, by the coincident increase in the use of pharmacological agents as a first-line therapy. The popularity of medical therapy might also and zovirax and soma, for instance, chicos soma. Purchase soma carisoprodolThe hospital records documented every drug provided to each patient, and the records of patients who received lmwh, ufh, or other anticoagulants were identified and zyban. WHO SHOULD NOT TAKE ORAL CONTRACEPTIVES Cigarette smoking increases the risk of serious adverse effects on the heart and blood vessels from oral contraceptive use. This risk increases with age and with heavy smoking 15 or more cigarettes per day ; and is quite marked in women over 35 years of age. Women who use oral contraceptives are strongly advised not to smoke. Some women should not use the pill. For example, you should not take the pill if you are pregnant or think you may be pregnant. You should also not use the pill if you have any of the following conditions: Heart attack or stroke blood clot or hemorrhage in the brain ; , currently or in the past. Blood clots in the legs thrombophlebitis ; , lungs pulmonary embolism ; , eyes, or elsewhere in the body, currently or in the past. Chest pain angina pectoris ; , currently or in the past. Known or suspected breast cancer or cancer of the lining of the uterus womb ; , cervix, or vagina, currently or in the past. Unexplained vaginal bleeding until a diagnosis is reached by your doctor ; . Yellowing of the whites of the eyes or of the skin jaundice ; during pregnancy or during previous use of the pill. Liver tumor whether cancerous or not ; , currently or in the past. Table 3.2 Large-Scale Trial Consolidations, 19932003. 10. Out of Network Payments under the [Key Advantage] Plan Under the [Key Advantage] Plan, when a Participant receives services from a nonnetwork Provider, the Company may choose to make payment directly to the Enrollee or, at the Company's sole option, to any other person responsible for payment of the Provider's charge. Payment will be made only after the Company has received an itemized bill and the medical information the Company decides is necessary to process the claim. The Company will pay to the Enrollee 75% of the amount the Plan would have paid to a network Provider for the same service. The Enrollee will also be responsible for the difference between the Plan's allowance and the Provider's charge. Payment by the Company will relieve it of any further liability for the nonnetwork Provider's services. 11. Alternative Benefits The Company may elect to offer benefits for an approved, alternative treatment plan for a patient who would otherwise require more expensive services, including, but not limited to, long-term Inpatient care. The Company shall provide such alternative benefits at its sole option and only when and for so long as the Company decides that the alternative services are Medically Necessary and cost-effective. The total benefits paid for such services may not exceed the total which would otherwise be paid under this contract without alternative benefits. If the Company elects to provide alternative benefits for a Participant in one instance, it shall not be required to provide the same or similar benefits for any Participant in any other instance. Also, this shall not be construed as a waiver of the State's right to administer this contract in the future in strict accordance with its express terms. 12. Organ Transplants When the recipient of a human organ or tissue transplant is a Participant, Inpatient services as well as outpatient services rendered in anticipation of Inpatient services ; which are rendered to the donor in connection with the transplant procedure shall be treated as services which are rendered to the Participant. However, benefits for these services are limited to only those not available to the donor from any other source, including, but not limited to other insurance coverage or any government program. When only the donor is a Participant, Inpatient services as well as outpatient services rendered in anticipation of Inpatient services ; which are rendered to the donor in connection with the transplant procedure shall not be eligible for reimbursement. This paragraph will not limit services rendered to the donor Participant after his discharge date. 13. Appeals You have the right to request the Company to review the denial of any claim. There are strict time limits on each stage of appeal. You will be notified of these limits in correspondence which denies your claim. Look for and observe these strict time limits. You must initiate an appeal to the company within 60 days of the Company's denial of your initial claim. Soma meditatie utrecht, soma technologies aura soma therapy, akane soma, lowest soma, soma s, soma corporation. Spliceosomal introns are largely quasi-random sequences that interrupt the coding regions of many eukaryotic genes. They are excised from mRNA transcripts by the spliceosome, an elaborate RNAprotein complex. The ultimate origins and evolutionary significance of spliceosomal introns have been hotly debated since their discovery 30 years ago for recent reviews, see Rogozin et al. 2005; Jeffares et al. 2006; Roy and Gilbert 2006 ; . A central issue is the relative importance of intron loss and gain through eukaryotic history. Introns are often found at the exact same positions in orthologous genes of widely divergent eukaryotic species Fedorov et al. 2002; Rogozin et al. 2003; Sverdlov et al. 2005 ; in a pattern suggesting intron-rich ancestors and massive recurrent intron loss along diverse lineages Roy and Gilbert 2005b ; . This view is supported by the apparent presence of a complex spliceosome in the eukaryotic ancestor Collins and Penny 2005 ; and by the two available genome-wide studies of more closely related species Roy et al. 2003; Nielsen et al. 2004 ; . However, other analyses suggest more moderate ancestral intron densities Csuros 2005; Nguyen et al. 2005 ; , with a more central role for intron gain Babenko et al. 2004; Qiu et al. 2004 ; . The mechanisms of intron loss and gain also remain debated. New introns might arise either by 1 ; insertion of type II self-splicing introns laterally transferred from endosymbionts Sharp 1985; Cavalier-Smith 1991; Stoltzfus 1999 ; , 2 ; insertion of transposable elements into coding sequences Crick 1979; Iwamoto et al. 1998, 1999; Roy 2004 ; , or 3 ; reinsertion of a spliced RNA copy of an intron into a previously intron-less site of a transcript, followed by reverse transcription of this transcript and gene conversion Cavalier-Smith 1985; Palmer and Logsdon Jr. 1991; Coghlan and Wolfe 2004; Logsdon Jr. 2004; Sverdlov et al. 2004 ; . Intron loss might occur by recombination with a reversetranscribed copy of a spliced mRNA transcript Perler et al. 1980 and sonata. K.R. Meltzer, MS, P.R. Standley, PhD; Department of Physiology, Midwestern University AZCOM, Glendale, AZ The cellular basis for osteopathic manipulative therapies OMTs ; remains elusive. Previously, we described an in vitro cellular strain model useful in deciphering potential cellular mediators of OMT. In the current study, we further this work by investigating interleukin IL ; secretory profiles from human fibroblasts that were exposed to various strain regimens. Fibroblasts were exposed to 1 ; an eight-hour hammering strain, 2 ; a 60 second counterstrain, or 3 ; both profiles. We hypothesized that hammering would increase pro-inflammatory IL secretion and that counterstrain would reverse this effect and or increase anti-inflammatory IL secretion. Conditioned media obtained immediately post-hammering IPH ; , 24 hours post-hammering 24PH ; , 24 hours post-counterstrain 24CS ; and 24 hours post-hammering plus counterstrain 24HCS ; were analyzed by cytokine array. Hammering notably ie, 2-fold change ; increased secretion of pro-inflammatory IL-1 alpha, IL-1 beta and IL-16. While secretion of IL-16 was observed in the IPH group, secretion of IL-1 alpha and IL-1 beta were delayed seen in 24PH ; . Hammering also induced antiinflammatory IL-1 receptor antagonist secretion. Simulated OMT 24CS ; induced secretion of two dual action cytokines possessing both anti- and pro-inflammatory properties IL13 and IL-16 ; and also stimulated secretion of five pro-inflammatory ILs IL-1 alpha, IL-3, IL-6, IL-7, IL-15 ; . The combination of hammering followed by counterstrain induced secretion of fewer pro-inflammatory ILs compared to counterstrain alone. The current study clearly shows that strain profiles designed to mimic injury and OMT elicit different types and quantities of interleukin secretion. The ultimate inflammatory outcome post-strain appears to result from the balance between pro- and anti-inflammatory cytokine actions. These data suggest that OMT may result in anti-inflammatorybased clinical outcome in the long run, but within 24 hours of counterstrain the data may also support a role for ILs in post-treatment flare by modulating local fibroblast-derived ILs. Acknowledgment: This work was funded by National Institutes of Health Grant P-01 AT2023 National Center for Complimentary and Alternative Medicine ; to PRS. and an in vitro cellular strain apparatus, we reported that acyclic heterobiaxial strain for 48 hours at 110% of resting cell length induces morphological alterations and increases proliferation and IL-6 secretion. As various OMTs strain cells and tissues differentially, we sought to determine if acyclic equiradial strain induces equivalent alterations. Materials and Methods: Cultured HF were equiradially strained acyclically for 48 hours at 110%. HF morphology and actin architecture were microscopically assessed, while proliferation was estimated using Owen's reagent and by quantifying the cellular protein to dsDNA ratio. Cytokine secretion was assessed from strained and control HF cultures using a cytokine antibody array. Results: Equiradial strain resulted in no morphological alterations and no change in HF proliferation. However, there was 42 5% decrease in IL-6 content in conditioned media of strained cells. Additional downregulated cytokines included FGF-6, IL-15, IFN- , PDGF-BB, RANTES, TNF- , and TNF- . Cytokines whose secretions were increased with strain include angiogenin, BMP-4, Eotaxin, and FGF-7. Conclusions: When comparing heterobiaxial and equiradial strains of equal magnitude, frequency and duration, we observed divergent effects on HF morphology, proliferative response and cytokine secretion. Since various OMTs impart differential biophysical strains in vivo, we suggest that this translates to differential cellular responses with respect to fibrosis, cytokine secretion, etc. If true, such diversity in cellular responses may underlie the relative efficacies of each OMT in treating various somatic dysfunctions. Acknowledgment: Funding for these studies was made possible by grants awarded to PRS from the NIH and the National American Heart Association. PartnerFSucampo Pharmaceuticals, Inc. Bethesda, Maryland ; LicensingFU.S. and Canadian marketing rights for Lubiprostone i Takeda has obtained the option right to Europe and Japan. j Expected IndicationFFunctional Constipation and Constipation predominant Irritable Bowel Syndrome c-IBS ; Development stageFfunctional constipation Ph-III completed. August 11, 1996 STN released the first version of a Messenger enhancement for ORDERing fulltext from journal articles cited in SWETSCAN. It is now possible to use the ORDER command with an L# answer set, containing an article in the DISPLAY format OF. In this release it is not yet possible to select one article from a table of contents. 21 of the 29 document suppliers are able to deliver journal articles. SWETSCAN is a weekly table of contents service offering access to the tables of contents of over 13, 000 scholarly journals very soon after publication. The current database contains information about some 5.5 million articles from 300, 000 tables of contents. 723 THE DEVELOPMENT AND USE OF A cDNA MICROARRAY TO EXPLORE GENDER ASSOCIATED GENE EXPRESSION IN SCHISTOSOMA JAPONICUM. Fitzpatrick JM, Bergholdt C, Vang Johansen M, Johnston DA, Dunne DW, Hoffmann KF. Department of Pathology, University of Cambridge, United Kingdom; Danish Bilharziasis Laboratory, Denmark; Department of Zoology, Natural History Museum, United Kingdom. Adult schistosomes are sexually dimorphic, where the initiation of sexual maturation in the female schistosome is dependent upon certain stimuli from the male. While little is known regarding these molecular signals and cellular triggers, sexual maturity in the female permits the worm to lay up to 3500 eggs per day. Moreover, as the egg instigates host pathology, explication of sexual maturation will lead to a greater appreciation of parasite-derived immuno-pathology. A novel Schistosoma japonicum specific cDNA microarray was fabricated with 455 cDNA elements. Utilizing this functional genomic tool, we explored sex linked transcript expression. Additionally, a comparison of S. japonicum strains Anhui Zheijang ; was also performed. The non-redundant cDNAs were PCR amplified from three independent cDNA libraries isolated from mixed sex adult worm, egg and miracidia. Database sequence comparisons revealed that 45% of the cDNAs display significant similarity to known genes. Sexuallymature adult worm material, isolated from mice at six weeks post-infection was used as a target. Independent batches of infected mice and hybridization experiments allowed a comprehensive statistical analysis of differential transcript expression. Through bimodal comparisons, systematic hybridization identified novel sex- and strain-associated gene transcripts. RT-PCR analysis for a significant sub-set of genes confirmed the expression patterns identified. Functional characterization of these transcripts will ensue, including targeted gene knock-down. A well-characterized, quality controlled S. japonicum cDNA microarray was generated, and its application in studying parasite related gene expression illustrated. Utilizing either this cDNA microarray, or the expression information obtained herein, a platform is provided to expand upon the biology and interactions of the genes identified. This will accelerate the.
|